MedTrace Logo

Ultrasound Evaluation of Lower Extremity Arteries After Topical Nitroglycerin Administration

NCT04155476 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-11-08

No results posted yet for this study

Summary

There have not been any published studies showing the use of topical nitroglycerin on the dilatory effect on the posterior tibial or dorsalis pedis arteries. The objective of this study is to determine the response of the posterior tibial artery and dorsalis pedis artery to topical administration of nitroglycerin. This study may provide further information for the utility of this artery in the treatment of peripheral arterial disease.

Conditions

  • Peripheral Arterial Disease

Interventions

DRUG

Nitroglycerin Topical Product

application of NG topical to dorsals pedis and posterior tibial arteries.

Sponsors & Collaborators

  • Deborah Heart and Lung Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-30
Primary Completion
2020-03-30
Completion
2020-03-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04155476 on ClinicalTrials.gov